Pancreatic Cancer Research

ResearcherHonorHealthActive in the last 2 years

Alexa F. Viniotis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8990-4684; OpenAlex author ID A5117013304. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

  1. A phase II clinical trial of albumin-bound paclitaxel, cisplatin, gemcitabine (NABPLAGEM), and paricalcitol as neoadjuvant therapy in pancreatic cancer. Co-author DOI 10.1093/oncolo/oyag232↗
  2. Retrospective analysis of capecitabine maintenance therapy in pancreatic ductal adenocarcinoma. First author DOI 10.1177/17588359251321894↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gayle Jameson · 2 shared papers, 2025–2026 · strength 0.53
  2. Erkut Hasan Borazanci · 2 shared papers, 2025–2026 · strength 0.53
  3. Jordan Powell · 1 shared paper, 2025 · strength 0.30
  4. Albert Amini · 1 shared paper, 2026 · strength 0.22
  5. Ronald Lee Korn · 1 shared paper, 2026 · strength 0.22
  6. Syed Rahmanuddin · 1 shared paper, 2026 · strength 0.22
  7. Ronald M. Evans · 1 shared paper, 2026 · strength 0.22
  8. Daniel D. Von Hoff · 1 shared paper, 2026 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.